BioSpace News Archive

Genetown

Molecular Loop Biosciences launches Monkeypox Research Sequencing Panels

Molecular Loop Biosciences, Inc., announced today that it has launched monkeypox targeting panels to support researchers conducting monkeypox viral surveillance and variant discovery.

September 28, 2022
·
2 min read
Rising Demand for Medicines Related to the Treatment of Follicular Lymphoma is Expected to Drive Follicular Lymphoma Treatment Market Growth by 2030 | Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Follicular Lymphoma Treatment Market – Forecast to 2030,’ thoroughly examines the Follicular Lymphoma Treatment industry to provide essential data & information for the targeted readers.

September 28, 2022
·
6 min read
Rising Smoking Rates, and Aging Population are Expected to Drive Peptic Ulcer Treatment Market Growth by 2030 | Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Peptic Ulcer Treatment Market – Forecast to 2030,’ thoroughly examines the Peptic Ulcer Treatment industry to provide essential data & information for the targeted readers

September 28, 2022
·
6 min read
Increasing Birth Rate of New-borns is Expected to Drive Poliomyelitis Market Growth by 2030 | Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Poliomyelitis Market – Forecast to 2030,’ thoroughly examines the Poliomyelitis industry to provide essential data & information for the targeted readers.

September 28, 2022
·
5 min read
Rising Prevalence of Lysosomal Storage Disorders Across the Globe is Expected to Drive Pompe Disease Treatment Market Growth by 2030 | Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Pompe Disease Treatment Market – Forecast to 2030,’ thoroughly examines the Pompe Disease Treatment industry to provide essential data & information for the targeted readers.

September 28, 2022
·
6 min read
BioCapital

careviso Raises Over $17 million in Series B Funding to Enhance Transparency and Access for Diagnostic Testing

careviso, a healthcare technology company and market leader in molecular diagnostic patient access technology (the “Company”), today announced that it has raised over $17 million in Series B funding led by Ballast Point Ventures with participation from existing investors Mercury and Lytical Ventures.

September 28, 2022
·
4 min read
Pharm Country

Mitsubishi Tanabe Pharma America Celebrates Nearly 2,000 ALS Patients Treated With RADICAVA ORS® (edaravone)

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that nearly 2,000 people with amyotrophic lateral sclerosis (ALS) have received RADICAVA ORS® (edaravone).

September 28, 2022
·
9 min read
Business

NOTA Laboratories Signs Joint Development Agreement With NGK Sparkplugs

NOTA Laboratories, a development stage company focused on proprietary nitric oxide (NO) delivery systems to treat a wide variety of acute and chronic respiratory and inflammatory illnesses, has just signed a Joint Development Agreement with NGK Spark Plugs of Nagoya, Japan.

September 28, 2022
·
2 min read
Biotech Bay

Gladstone Institutes Joins the Parker Institute for Cancer Immunotherapy Network

Gladstone Institutes has partnered with the Parker Institute for Cancer Immunotherapy, the leading network of immuno-oncology expertise in the world, to establish a new research center focused on using genomics and CRISPR technology to program the human immune system to treat cancer.

September 28, 2022
·
4 min read
Business

Lyell Immunopharma Announces the Appointment of Rahsaan Thompson as Chief Legal Officer

Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company dedicated to developing curative cell therapies for patients with solid tumors, announced that Rahsaan W. Thompson has joined the executive management team as chief legal officer.

September 28, 2022
·
4 min read